Site US1009 — Marietta, Georgia

Site US1009 is a clinical research site located in Marietta, Georgia, United States 30067.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site US1009 has participated in 1 clinical trials.

Therapeutic areas: Urinary Bladder Overactive, Overactive Bladder, Urinary Bladder Diseases.

Sponsors: Astellas Scientific & Medical Affairs, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Marietta

Browse all research sites in Georgia · View every site in Marietta

• Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital
• WellStar Health System-Kennestone Hospital
• Northside Hospital, Inc. GCS/Kennestone
• Wellstar Hospitals
• WellStar Cobb Hospital, WellStar Kennestone Hospital
• Wellstar Hospital
• Northside Hospital, Inc.-Georgia Cancer Specialists
• Wellstar Kennestone Hospital
• Northside Hospital
• Life University
• Kennestone Cancer Center at Wellstar Kennestone Hospital
• Northside Hospital, Inc. - GCS/Marietta

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US1009?

Site US1009 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US1009 conducted?

Site US1009 has 1 clinical trials on record. Their work covers Urinary Bladder Overactive, Overactive Bladder, Urinary Bladder Diseases.

Is Site US1009 accredited by Crixeo Clinical Trials?

Site US1009 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US1009?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.